BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1007751)

  • 1. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of endoperoxides and thromboxanes in anaphylactic reactions.
    Hamberg M; Svensson J; Hedqvist P; Strandberg K; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():495-501. PubMed ID: 998440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1975 Jun; 94(2):222-8. PubMed ID: 1155178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
    Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
    J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
    Svensson J
    Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):2994-8. PubMed ID: 1059088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.
    Jones RL; Peesapati V; Wilson NH
    Br J Pharmacol; 1982 Jul; 76(3):423-38. PubMed ID: 6286023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1977; 14(6):1043-53. PubMed ID: 601247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
    Moncada S; Gryglewski R; Bunting S; Vane JR
    Nature; 1976 Oct; 263(5579):663-5. PubMed ID: 802670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of a novel TXA2/PGH2 receptor ligand (S-145) in platelets and vascular and airway smooth muscle.
    Dubé GP; Mais DE; Jakubowski JA; Brune KA; Utterback BG; True TA; Rinkema LE; Kurtz WL
    J Pharmacol Exp Ther; 1992 Aug; 262(2):784-91. PubMed ID: 1386888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
    [No Abstract]   [Full Text] [Related]  

  • 13. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.
    Bunting S; Gryglewski R; Moncada S; Vane JR
    Prostaglandins; 1976 Dec; 12(6):897-913. PubMed ID: 1005741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.
    Schrör K; Moncada S; Ubatuba FB; Vane JR
    Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
    Gryglewski RJ; Dembínska-Kieć A; Korbut R
    Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
    Eakins KE; Kulkarni PS
    Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboxane A2: effects on airway and vascular smooth muscle.
    Svenssen J; Strandberg K; Tuvemo T; Hamberg M
    Prostaglandins; 1977 Sep; 14(3):425-36. PubMed ID: 905570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic acid inhibits thromboxane synthesis in platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1978 Apr; 15(4):629-36. PubMed ID: 674694
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.
    Hamberg M; Svensson J; Wakabayashi T; Samuelsson B
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):345-9. PubMed ID: 4521806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.